unknown
Stage
About
Xap Therapeutics develops tailor-made cellular therapies using genome editing and synthetic biology to create programmable immune cells designed to precisely target and treat complex diseases such as cancer and autoimmunity.
Explore Xap Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.